Stoxx Europe 50
|
4 818,60
|
40,38
|
0,85 %
|
Analysen zu Stoxx Europe 50-Werten
| 12.02.25 | BP Buy | Goldman Sachs Group Inc. | |
| 11.02.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 11.02.25 | BP Verkaufen | DZ BANK | |
| 11.02.25 | BP Buy | Goldman Sachs Group Inc. | |
| 11.02.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 11.02.25 | Schneider Electric Outperform | Bernstein Research | |
| 11.02.25 | ABB Underperform | Bernstein Research | |
| 11.02.25 | EssilorLuxottica Outperform | RBC Capital Markets | |
| 11.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 11.02.25 | L'Oréal Sell | Deutsche Bank AG | |
| 11.02.25 | UniCredit Buy | Jefferies & Company Inc. | |
| 11.02.25 | BP Sector Perform | RBC Capital Markets | |
| 11.02.25 | L'Oréal Underweight | JP Morgan Chase & Co. | |
| 11.02.25 | Santander Kaufen | DZ BANK | |
| 11.02.25 | BP Buy | Jefferies & Company Inc. | |
| 11.02.25 | BP Underweight | JP Morgan Chase & Co. | |
| 11.02.25 | UBS Buy | Deutsche Bank AG | |
| 11.02.25 | BP Buy | UBS AG | |
| 11.02.25 | UniCredit Overweight | JP Morgan Chase & Co. | |
| 11.02.25 | RELX Outperform | Bernstein Research | |
| 11.02.25 | AstraZeneca Outperform | Bernstein Research | |
| 11.02.25 | LVMH Moet Hennessy Louis Vuitton Neutral | UBS AG | |
| 11.02.25 | EssilorLuxottica Neutral | UBS AG | |
| 11.02.25 | Richemont Buy | UBS AG | |
| 11.02.25 | Prosus Overweight | JP Morgan Chase & Co. | |
| 11.02.25 | UBS Outperform | RBC Capital Markets | |
| 11.02.25 | VINCI Outperform | RBC Capital Markets | |
| 11.02.25 | ABB Neutral | Goldman Sachs Group Inc. | |
| 11.02.25 | Airbus Neutral | UBS AG | |
| 11.02.25 | EssilorLuxottica Buy | Jefferies & Company Inc. | |
| 10.02.25 | Santander Sector Perform | RBC Capital Markets | |
| 10.02.25 | L'Oréal Halten | DZ BANK | |
| 10.02.25 | Novo Nordisk Buy | UBS AG | |
| 10.02.25 | BAT Buy | UBS AG | |
| 10.02.25 | SAFRAN Outperform | RBC Capital Markets | |
| 10.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.02.25 | GSK Hold | Deutsche Bank AG | |
| 10.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 10.02.25 | VINCI Buy | Deutsche Bank AG | |
| 10.02.25 | Intesa Sanpaolo Buy | Goldman Sachs Group Inc. |